# PTC Drug Sensitivity Detection to Guide Postoperative Adjuvant of Colorectal Cancer

> **NCT05978349** · NA · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 150 (estimated)

## Conditions studied

- Colo-rectal Cancer

## Interventions

- **DRUG:** adjuvant therapy based on 3D drug sensitivity test results of micro tumor (PTC) in vitro

## Key facts

- **NCT ID:** NCT05978349
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-14
- **Primary completion:** 2025-09-30
- **Final completion:** 2025-09-30
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2023-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05978349

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05978349, "PTC Drug Sensitivity Detection to Guide Postoperative Adjuvant of Colorectal Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05978349. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*